Ann Kurth, PhD, MPH, MSN, CNM, FAAN
About
Research
Publications
2025
Barriers to and impacts of hepatitis C treatment among people who inject drugs in Kenya: A qualitative study
Manley H, Riback L, Nyakowa M, Akiyama M, Cherutich P, Lizcano J, Kurth A, Muller A. Barriers to and impacts of hepatitis C treatment among people who inject drugs in Kenya: A qualitative study. PLOS Global Public Health 2025, 5: e0003284. PMID: 39821143, PMCID: PMC11737709, DOI: 10.1371/journal.pgph.0003284.Peer-Reviewed Original ResearchDrop-in-centersRhodes' risk environment framework,HCV-related stigmaReduce barriers to treatmentSystem-level changesBarriers to treatmentMiddle-income countriesTreatment programsBarriers to HCV treatmentRisk environment frameworkExperiences of PWIDHCV treatment programSemi-structured interviewsBarriers patientsHCV treatmentLMIC settingsTranscribed interviewsThematic analysisCase managementQualitative studyPositive treatment outcomesTreatment accessRisk behaviorsImplementing treatment programsPWID
2024
Widespread hepatitis C virus transmission network among people who inject drugs in Kenya
Akiyama M, Khudyakov Y, Ramachandran S, Riback L, Ackerman M, Nyakowa M, Arthur L, Lizcano J, Walker J, Cherutich P, Kurth A. Widespread hepatitis C virus transmission network among people who inject drugs in Kenya. International Journal Of Infectious Diseases 2024, 147: 107215. PMID: 39182826, PMCID: PMC11531246, DOI: 10.1016/j.ijid.2024.107215.Peer-Reviewed Original ResearchGlobal Hepatitis Outbreak and Surveillance TechnologyHepatitis C virusHepatitis C virus strainsTransmission clustersHCV transmission networksHepatitis C virus eliminationHepatitis C virus burdenHypervariable region 1C virusGenotype 1aCity of MombasaInjected drugsCoastal city of MombasaNext-generation sequencing dataHepatitis C virus hypervariable region 1PWIDSyringe programsSequence dataSurveillance technologiesDrugIncome countriesKilifiNairobiPolysubstance Use and Related Risk Behaviors among People Who Inject Drugs in Kenya Preparing for Hepatitis C Virus Treatment
Riback L, Nyakowa M, Lizcano J, Zhang C, Cherutich P, Kurth A, Akiyama M. Polysubstance Use and Related Risk Behaviors among People Who Inject Drugs in Kenya Preparing for Hepatitis C Virus Treatment. Viruses 2024, 16: 1277. PMID: 39205251, PMCID: PMC11359571, DOI: 10.3390/v16081277.Peer-Reviewed Original ResearchMedication-assisted treatmentInjection drug usePolysubstance useHepatitis C virusReducing injection drug useBloodborne infectionsHepatitis C virus treatmentAssociated with injection drug useHepatitis C virus transmissionCannabis useMultivariate logistic regressionEquipment sharingCannabisDrug useHIV-positiveHCV treatmentAcquisition riskHeroinC virusPolysubstanceRisk behaviorsInjected drugsAccess needleRelated risk behaviorsRe-infectionThe “15-Minute City” Concept in the Context of the COVID-19 Pandemic and Climate Change
Vlahov D, Kurth A. The “15-Minute City” Concept in the Context of the COVID-19 Pandemic and Climate Change. Journal Of Urban Health 2024, 101: 669-671. PMID: 39026127, PMCID: PMC11329452, DOI: 10.1007/s11524-024-00897-1.Peer-Reviewed Original Research
News
News
- September 18, 2024
YSPH urges bold action at Climate Week NYC
- November 28, 2022
Yale Institute for Global Health Brings Researchers Together to Improve World Health
- December 05, 2021
YSM's Power Day Highlights Role of "Radical Listening" in Using Power Well
- April 27, 2021Source: Yale Nursing website
A Sprint and a Marathon: Nursing Leaders from Across CT Debrief COVID-19 Strategies at Bellos Lecture